Allen R. Nissenson, MD, FACP
Industry Speaks III: IV Iron Therapy: A Practical Approach to Patient Management
UMX53-040
25th Annual Conference on Peritoneal Dialysis ~ 2005
Treating the Iron Dextran Intolerant Patient - Chaim Charytan, MD
Determining the Optimal Maintenance Dose - Allen R. Nissenson, MD
Safety of IV Iron Agents - George R. Bailie, PharmD, PhD
Case Studies in IV Iron Agents - Joel D. Glickman, MD
Discussion
Adjourn